Last filing: Oct 5, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| MetLife (MET) | Director | Nov 2, 2018 | Oct 5, 2026 |
| Vertex Pharmaceuticals (VRTX) | Director | Jun 5, 2020 | May 5, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, MetLife: 544 shares awarded. 1 filing: 1
- Sep 8, 2026, MetLife: 157 shares awarded. 1 filing: 1
- Jun 16, 2026, MetLife: 587 shares awarded. 1 filing: 1
- Jun 9, 2026, MetLife: 169 shares awarded. 1 filing: 1
- May 1, 2026, Vertex Pharmaceuticals: 943 shares granted; 796 shares returned to the company. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.